Cardiovascular Research Advance Access originally published online on June 1, 2009
Cardiovascular Research 2009 84(1):127-136; doi:10.1093/cvr/cvp177
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells
1 First Department of Internal Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan
2 Department of Bioscience, National Cardiovascular Center Research Institute, Osaka, Japan
3 International Research and Educational Institute for Integrated Medical Sciences, Tokyo Women's University, Tokyo, Japan
4 Department of Physiology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
5 Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
6 Hoshi General Hospital, Fukushima, Japan
* Corresponding author. Tel: +81 24 547 1190; fax: +81 24 548 1821. E-mail address: masaishi{at}fmu.ac.jp
Aims: RhoA and Rac1 activation plays a key role in endothelial dysfunction. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a major receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial cells (ECs). Membrane type 1 matrix metalloproteinase (MT1-MMP) has been shown to be involved in atherogenesis. This study was conducted to investigate the role of the LOX-1-MT1-MMP axis in RhoA and Rac1 activation in response to ox-LDL in ECs.
Methods and results: Ox-LDL induced rapid RhoA and Rac1 activation as well as MT1-MMP activity in cultured human aortic ECs. Inhibition of LOX-1 prevented ox-LDL-dependent RhoA and Rac1 activation. Knockdown of MT1-MMP by small interfering RNA prevented ox-LDL-induced RhoA and Rac1 activation, indicating that MT1-MMP is upstream of RhoA and Rac1. Fluorescent immunostaining revealed the colocalization of LOX-1 and MT1-MMP, and the formation of a complex of LOX-1 with MT1-MMP was detected by immunoprecipitation. Blockade of LOX-1 or MT1-MMP prevented RhoA-dependent endothelial NO synthase protein downregulation and cell invasion, Rac1-mediated NADPH oxidase activity, and reactive oxygen species generation.
Conclusion: The present study provides evidence that the LOX-1-MT1-MMP axis plays a crucial role in RhoA and Rac1 activation signalling pathways in ox-LDL stimulation, suggesting that this axis may be a promising target for treating endothelial dysfunction.
KEYWORDS LOX-1; MT1-MMP; RhoA; Rac1; Endothelial dysfunction
Time for primary review: 25 days